Evidence map›Paper›PMID 32424351›Full record

ArticleNature genetics2020

Spatial competition shapes the dynamic mutational landscape of normal esophageal epithelium.

Bartomeu Colom, Maria P Alcolea, Gabriel Piedrafita, Michael W J Hall, Agnieszka Wabik, Stefan C Dentro, Joanna C Fowler, Albert Herms, Charlotte King, Swee Hoe Ong and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 166 citations in OpenAlex.

  1. Epigenetic silencingCancer biology & therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Esophageal cancer: from pathogenesis to precision therapies.Signal transduction and targeted therapy · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Age distinguishes selection from causation in cancer genomes.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. EarlybioRxiv : the preprint server for biology · 2025
    Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Bartomeu ColomWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-6256-6462
Maria P Alcolea *Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Gabriel Piedrafita *Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-8701-1084
Michael W J HallWellcome Sanger Institute, Hinxton, UK.
Agnieszka WabikWellcome Sanger Institute, Hinxton, UK.
Stefan C DentroWellcome Sanger Institute, Hinxton, UK.
Joanna C FowlerWellcome Sanger Institute, Hinxton, UK.
Albert HermsWellcome Sanger Institute, Hinxton, UK.
Charlotte KingWellcome Sanger Institute, Hinxton, UK.
Swee Hoe OngWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-3629-5387
Roshan K SoodWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-1318-7025
Moritz GerstungEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK.ORCID http://orcid.org/0000-0001-6709-963X
Inigo MartincorenaWellcome Sanger Institute, Hinxton, UK.
Benjamin A HallMRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK. bh418@mrc-cu.cam.ac.uk.ORCID http://orcid.org/0000-0003-0355-2946
Philip H JonesWellcome Sanger Institute, Hinxton, UK. pj3@sanger.ac.uk.ORCID http://orcid.org/0000-0002-5904-795X
Wellcome Sanger Institute · GBUniversity of Cambridge · GBEuropean Bioinformatics Institute · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Cancer Research UK 17257Cancer Research UK 21777Cancer Research UK A17257Cancer Research UK A21777Cancer Research UK A27326Cancer Research UK C57387/A21777Cancer Research UK C609/A17257Cancer Research UK C609/A27326Medical Research Council MC_PC_12009Medical Research Council MC_PC_17230Medical Research Council MC_UU_12022/9Medical Research Council MR/S000216/1Wellcome Trust 098051Wellcome Trust 296194
6 · The paper itself

Abstract

During aging, progenitor cells acquire mutations, which may generate clones that colonize the surrounding tissue. By middle age, normal human tissues, including the esophageal epithelium (EE), become a patchwork of mutant clones. Despite their relevance for understanding aging and cancer, the processes that underpin mutational selection in normal tissues remain poorly understood. Here, we investigated this issue in the esophageal epithelium of mutagen-treated mice. Deep sequencing identified numerous mutant clones with multiple genes under positive selection, including Notch1, Notch2 and Trp53, which are also selected in human esophageal epithelium. Transgenic lineage tracing revealed strong clonal competition that evolved over time. Clone dynamics were consistent with a simple model in which the proliferative advantage conferred by positively selected mutations depends on the nature of the neighboring cells. When clones with similar competitive fitness collide, mutant cell fate reverts towards homeostasis, a constraint that explains how selection operates in normal-appearing epithelium.

Indexed as

MutationADAM10 ProteinAmyloid Precursor Protein SecretasesAnimalsCell LineageDiethylnitrosamineEpitheliumEsophagusFemaleHigh-Throughput Nucleotide SequencingMaleMembrane ProteinsMice, Inbred C57BLMice, TransgenicReceptor, Notch1Receptor, Notch2ADAM10 ProteinAdam10 protein, mouseAmyloid Precursor Protein SecretasesDiethylnitrosamineMembrane ProteinsNotch1 protein, mouseNotch2 protein, mouseReceptor, Notch1Receptor, Notch2Trp53 protein, mouseTumor Suppressor Protein p53

Identifiers

PMID32424351
PMCPMC7116672
OpenAlexW3025298198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.